Bardoux P, Ahloulay M, Le Maout S, Bankir L, Trinh-Trang-Tan M M
INSERM Unit 367, Paris, France.
Diabetologia. 2001 May;44(5):637-45. doi: 10.1007/s001250051671.
AIMS/HYPOTHESIS: Although the urine flow rate is considerably higher in diabetes mellitus, water reabsorption is greatly increased to concentrate an increased amount of solutes. Our study evaluated the expression of aquaporins and urea transporters, which are essential to the urinary concentration process.
Northern blot and immunoblot were used to quantify mRNA and proteins for aquaporin-2 (AQP2) as well as urea transporters UT-A1, UT-A2 and UT-B1, in subzones of the renal medulla of rats with streptozotocin-induced diabetes.
In these rats, glycaemia, urine flow rate and water reabsorption were respectively fourfold, nine-fold and fourfold those of control rats. The AQP2 protein isoforms were significantly up-regulated in outer and inner medulla. In the base and tip of inner medulla, UT-A1 mRNA was significantly up-regulated (three- and 1.3-fold, respectively) as well as the 117 kD protein (ten- and threefold, respectively) whereas the 97 kD protein was not changed or decreased twofold, respectively. This suggests that, in diabetes, the inner medullary collecting duct is endowed with more UT-A1, especially in its initial part. In the case of mRNA and proteins of UT-A2, located in thin descending limbs in the inner stripe of outer medulla, they were respectively not changed and down-regulated in diabetic rats.
CONCLUSION/INTERPRETATION: This study shows that in diabetes, the increased expression of AQP2 and UT-A1 in medullary collecting duct is consistent with an improved concentrating activity. In addition, the underexpression of UT-A2 and the overexpression of UT-A1 in the initial medullary collecting duct are reminiscent of the changes seen after experimental reduction of urine concentration or low protein feeding.
目的/假设:尽管糖尿病患者的尿流率显著更高,但水重吸收会大幅增加以浓缩增加的溶质。我们的研究评估了水通道蛋白和尿素转运蛋白的表达,它们对尿液浓缩过程至关重要。
采用Northern印迹法和免疫印迹法对链脲佐菌素诱导的糖尿病大鼠肾髓质各亚区中水通道蛋白2(AQP2)以及尿素转运蛋白UT-A1、UT-A2和UT-B1的mRNA和蛋白质进行定量分析。
在这些大鼠中,血糖、尿流率和水重吸收分别是对照大鼠的4倍、9倍和4倍。AQP2蛋白异构体在外髓和内髓中显著上调。在内髓基部和尖端,UT-A1 mRNA显著上调(分别为3倍和1.3倍)以及117 kD蛋白(分别为10倍和3倍),而97 kD蛋白分别未改变或下调2倍。这表明,在糖尿病中,内髓集合管具有更多的UT-A1,尤其是在其起始部分。对于位于外髓内带细降支中的UT-A2的mRNA和蛋白质,在糖尿病大鼠中它们分别未改变和下调。
结论/解读:本研究表明,在糖尿病中,髓质集合管中AQP2和UT-A1表达增加与浓缩活性改善一致。此外,UT-A2的低表达和内髓集合管起始部UT-A1的过表达让人联想到实验性降低尿液浓缩或低蛋白喂养后所见的变化。